Introduction to Doxepin
Doxepin is a tricyclic antidepressant approved by the FDA for major depressive disorder, anxiety, and insomnia.
It works by increasing serotonin (5-HT) and norepinephrine (NE) levels in the brain.
Doxepin also has antagonistic effects on various receptors including histamine (H1), α1 adrenergic, and muscarinic.
FDA-Approved Indications
Doxepin is approved for treating major depressive disorder, insomnia, and skin pruritus.
Topical formulations are effective for pruritus associated with conditions like atopic dermatitis.
Oral capsules and solutions are prescribed for managing anxiety and insomnia.
Mechanism of Action
Doxepin enhances neurotransmitter availability by preventing serotonin and norepinephrine reuptake.
It blocks histamine receptors, providing its antipruritic effects.
Additionally, it inhibits sodium and potassium channels in cardiac cells, widening its therapeutic profile.
Administration and Dosage
Doxepin is available in oral tablets, capsules, solutions, and topical creams.
Common initial doses for insomnia are 3-6 mg; for major depressive disorder, 25-75 mg nightly is standard.
Gradual titration is recommended for optimal dosing based on individual response.
Adverse Effects
Doxepin may cause sedation, weight gain, and anticholinergic side effects like dry mouth and constipation.
Topical applications can lead to local irritation like burning or tingling sensations.
Close monitoring is required for signs of overdose or interactions with other medications.
Contraindications and Warnings
Doxepin is contraindicated in patients with cardiovascular disorders and those who are breastfeeding.
Careful monitoring is necessary due to potential increased suicidality associated with antidepressants.
Avoid prescribing to individuals with hypersensitivity to the drug or its components.
Interprofessional Collaboration
A team-based approach is essential for effective treatment of major depressive disorder.
Collaboration among psychiatrists, primary care physicians, and pharmacists optimizes patient outcomes.
Education on medication adherence and potential side effects is crucial for patients.
Install Browsy